芪苈强心胶囊联合增强型体外反搏治疗对射血分数降低的老年慢性缺血性心力衰竭病人心功能的影响

doi:10.3969/j.issn.1003-9198.2022.04.018

[1] SHEN C, GE J. Epidemic of cardiovascular disease in China[J]. Circulation, 2018, 138(4): 342-344.
[2] AMBROSY A P, FONAROW G C, BUTLER J, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries[J]. J Am Coll Cardiol, 2014, 63(12): 1123-1133.
[3] MENTZ R J, O′CONNOR C M. Pathophysiology and clinical evaluation of acute heart failure[J]. Nat Rev Cardio, 2016, 13(1): 28-35.
[4] NORMAND C, KAYE D M, POVSIC T J, et al. Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology[J]. Lancet, 2019, 393(10175): 1045-1055.
[5] SUN J, ZHANG K, XIONG W J, et al. Clinical effects of a standardized Chinese herbal remedy, Qili Qiangxin, as an adjuvant treatment in heart failure: systematic review and meta-analysis[J]. BMC Complement Altern Med, 2016, 16: 201.
[6] 中华医学会心血管病学分会心力衰竭学组, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志, 2018, 46(10):760-789.
[7] AHLBOM M, HAGERMAN I, STAHLBERG M, et al. Increases in cardiac output and oxygen consumption during enhanced external counterpulsation[J]. Heart Lung Circ, 2016, 25(11): 1133-1136.
[8] DI PALO K E, BARONE N J. Hypertension and heart failure: prevention, targets, and treatment[J]. Heart fail Clin, 2020, 16(1): 99-106.
[9] ZHANG H, LI S, ZHOU Q, et al. Qiliqiangxin attenuates phenylephrine-induced cardiac hypertrophy through downregulation of MiR-199a-5p[J]. Cell Physiol Biochem, 2016, 38(5): 1743-1751.
[10] LIN S, WU X, TAO L, et al. The metabolic effects of traditional Chinese medication Qiliqiangxin on H9C2 cardiomyocytes[J]. Cell Physiol Biochem, 2015, 37(6): 2246-2256.
[11] ZHANG J, HUANG M, SHEN S, et al. Qiliqiangxin attenuates isoproterenol-induced cardiac remodeling in mice[J]. Am J Transl Res, 2017, 9(12): 5585-5593.
[12] LI X, ZHANG J, HUANG J, et al. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure[J]. J Am Coll Cardiol, 2013, 62(12): 1065-1072.
[13] RAZA A, STEINBERG K, TARTAGLIA J, et al. Enhanced external counterpulsation therapy: past, present, and future[J]. Cardiol Rev, 2017, 25(2): 59-67.
[14] XIONG Y, REN Y F, XU J, et al. Enhanced external counterpulsation inhibits endothelial apoptosis via modulation of BIRC2 and Apaf-1 genes in porcine hypercholesterolemia[J]. Intern J Cardiol, 2014, 171(2): 161-168.
[15] BECK D T, MARTIN J S, CASEY D P, et al. Enhanced external counterpulsation improves endothelial function and exercise capacity in patients with ischaemic left ventricular dysfunction[J]. Clin Exp Pharmacol Physiol, 2014, 41(9): 628-636.
[16] KIERNAN T J, BOILSON B A, TESMER L, et al. Effect of enhanced external counterpulsation on circulating CD34+ progenitor cell subsets[J]. Intern J Cardiology, 2011, 153(2): 202-206.
[17] 刘娟, 丁清清, 周白瑜, 等. 中国老年人肌少症诊疗专家共识(2021)[J]. 中华老年医学杂志, 2021, 40(8):943-952.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 10

Metrics

Recommended 10

[1]	LU Hao, DENG Hui, WANG Chun, DAI Yang, WANG Qin, WANG Qing. Characteristics of cardiopulmonary function, exercise endurance, and the levels of NT-proBNP and TNT in elderly patients with stable chronic heart failure [J]. Practical Geriatrics, 2023, 37(11): 1138-1142.
[2]	LI Shan-shu, LYU Yi-ning, GONG Hui-min, ZHANG Gai-gai. Meta-analysis of sacubitril valsartan in the treatment of elderly patients with chronic heart failure [J]. Practical Geriatrics, 2023, 37(10): 1023-1026.
[3]	. [J]. Practical Geriatrics, 2022, 36(6): 603-605.
[4]	. [J]. Practical Geriatrics, 2021, 35(8): 789-794.
[5]	QIN Shao-qiang, ZHANG Zhan-shuai, SHI Jin-zheng, LI Zhuo-ran, ZHAO Han-ting, WANG Ya-ling, LI Fang-jiang. Study on the efficacy and mechanism of sacubitril valsartan in the treatment of elderly patients with chronic heart failure [J]. Practical Geriatrics, 2021, 35(8): 837-839.
[6]	ZHAO Wen-xue, FAN Tian-shu, LU Miao, WANG Xiang-ming, ZHA Zhi-min, GUO Yan. Clinical characteristics of elderly patients with diastolic heart failure complicated with sarcopenia [J]. Practical Geriatrics, 2021, 35(8): 845-848.
[7]	CAI Jie, WEI Wei, ZHANG Yu-qing. Correlation of the levels of serum copeptin and the inflammatory factors with the ventricular remodeling in elderly patients with chronic heart failure [J]. Practical Geriatrics, 2021, 35(7): 701-704.
[8]	GUO Hui-Feng, YANG Jing-Ye, ZHANG Xing-Liang, LI Sheng-Qian. Effect of noninvasive positivepressure respiration on serum Nterminal probrain natriuretic peptide in elderly patients with chronic heart failure [J]. Practical Geriatrics, 2010, 24(2): 144-146.
[9]	ZHANG Jingjing, ZHU Xiaoxia, YAO Chunlei, WANG Wei. Correlation between control nutritional status score and heart failure in elderly patients with coronary artery disease [J]. Practical Geriatrics, 2024, 38(7): 697-700.
[10]	. [J]. Practical Geriatrics, 2024, 38(7): 743-747.